Literature DB >> 6684750

cis-Diamminedichloroplatinum: a cytostatic with an ototoxic effect.

S Hartwig, U Pettersson, J Stahle.   

Abstract

Among 74 patients treated with cis-diamminedichloroplatinum in total doses of 130-590 mg/m2 body surface area, high tone hearing loss was observed in 3. The caloric and rotatory responses were reduced in 3 other patients. Optokinetic responses remained normal in all patients.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6684750     DOI： 10.1159/000275652

Source DB:  PubMed          Journal:  ORL J Otorhinolaryngol Relat Spec        ISSN： 0301-1569            Impact factor:   1.538


  4 in total

1.  The importance of high-tone audiometry in monitoring for ototoxicity.

Authors:  R A Tange; W A Dreschler; R J van der Hulst
Journal:  Arch Otorhinolaryngol       Date:  1985

2.  Cisplatin-induced ototoxicity: audiometric findings and experimental cochlear pathology.

Authors:  K Böheim; E Bichler
Journal:  Arch Otorhinolaryngol       Date:  1985

3.  Analysis of risk factors for cisplatin-induced ototoxicity in patients with testicular cancer.

Authors:  C Bokemeyer; C C Berger; J T Hartmann; C Kollmannsberger; H J Schmoll; M A Kuczyk; L Kanz
Journal:  Br J Cancer       Date:  1998-04       Impact factor: 7.640

4.  Vestibulotoxicity Associated With Platinum-Based Chemotherapy in Survivors of Cancer: A Scoping Review.

Authors:  Pattarawadee Prayuenyong; John A Taylor; Stephanie E Pearson; Rachel Gomez; Poulam M Patel; Deborah A Hall; Anand V Kasbekar; David M Baguley
Journal:  Front Oncol       Date:  2018-09-25       Impact factor: 6.244
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.